Skip to main content

Table 4 Healthcare costs among FN patients and matched comparison patients

From: Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

Healthcare Resources

Mean (95% CI), in British pounds

Overall*

Index Cycle

Post-Index Cycles

FN Patients (n = 295)

Comparison Patients (n = 295)

Difference

FN Patients (n = 295)

Comparison Patients (n = 295)

Difference

FN Patients (n = 295)

Comparison Patients (n = 295)

Difference

Total Cost of FN, Overall

8,066(7,277, 8,882)

2,290(1,923, 2,655)

5,776(4,928, 6,713)

4,051(3,633, 4,485)

---

4,051(3,633, 4,485)

4,015(3,374, 4,724)

2,290(1,923, 2,655)

1,725(978, 2,498)

Inpatient Care

6,007(5,278, 6,771)

543(287, 858)

5,463(4,709, 6,322)

3,942(3,520, 4,372)

---

3,942(3,520, 4,372)

2,065(1,478, 2,694)

543(287, 858)

1,522(900, 2,180)

Outpatient Care

180(123, 252)

130(56, 219)

50(−37, 144)

65(43, 89)

---

65(43, 89)

115(62, 182)

130(56, 219)

−15 (−97, 74)

Home Care

1,673(1,452, 1,899)

1,447(1,220, 1,674)

225(−78, 545)

41(26, 59)

---

41(26, 59)

1,632(1,409, 1,853)

1,447(1,220, 1,674)

184(−117, 503)

Other/Unknown Care

207(135, 293)

169(97, 253)

38(−67, 152)

4(2, 5)

---

4(2, 5)

203(131, 289)

169(97, 253)

34(−71, 148)

Total Cost of FN, by Setting of Care

Inpatient Episode

9,688(8,709, 10,653)

2,430(1,984, 2,931)

7,259(6,327, 8,205)

5,281(4,810, 5,774)

---

5,281(4,810, 5,774)

4,407(3,613, 5,225)

2,430(1,984, 2,931)

1,978(1,262, 2,801)

Outpatient Episode

3,761(1,908, 6,007)

1,777(1,116, 2,565)

1,984(−193, 4,177)

341(293, 435)

---

341(293, 435)

3,420(1,529, 5,676)

1,777(1,116, 2,565)

1,644(−521, 3,853)

Home Episode

3,291(2,445, 4,339)

1,826(993, 2,919)

1,466(234, 2,495)

324(241, 415)

---

324(241, 415)

2,967(2,124, 4,059)

1,826(993, 2,919)

1,141(−99, 2,176)

Other/Unknown Episode

2,211(1,140, 3,425)

1,850(766, 3,157)

361(−956, 1,650)

104(51, 205)

---

104(51, 205)

2,107(1,052, 3,333)

1,850(766, 3,157)

258(−1,031, 1,558)

  1. *Mean costs from index cycle through end of the chemotherapy course.